Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2026-02-19 @ 6:24 AM
Study NCT ID:
NCT01848756
Status:
TERMINATED
Last Update Posted:
2017-02-09
First Post:
2013-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of SNX-5422 in Human Epidermal Growth Factor Receptor 2 (HER2) Positive Cancers
Sponsor:
Esanex Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-04
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-06
Completion Date Type:
ACTUAL
First Submit Date:
2013-05-03
First Submit QC Date:
None
Study First Post Date:
2013-05-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-04-01
Results First Submit QC Date:
None
Results First Post Date:
2016-11-21
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-12-15
Last Update Post Date:
2017-02-09
Last Update Post Date Type:
ESTIMATED